Natasha K Stout1, Larissa Nekhlyudov. 1. Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA 02215, USA. natasha_stout@hms.harvard.edu
Abstract
BACKGROUND: Clinical applications of magnetic resonance imaging (MRI) of the breast have expanded across the breast cancer detection and control spectrum over the past decade. Use appears to be growing, although evidence for or against its use is still accumulating. METHODS: Using electronic health plan and medical record data, we documented early trends in breast MRI use from 2000 through 2004 in a large community practice setting with approximately 82,000 eligible female patients. During the study period, 225 women received at least one breast MRI; of those, 64 had subsequent MRI (for a total of 333 MRIs). RESULTS: Utilization grew from 6 MRIs in 2000 to 112 in 2004, with increasing use for screening, diagnosis, disease staging/treatment, and surveillance purposes. Diagnostic use accounted for nearly half of the breast MRIs (164 of 333). In this community-based practice, there was rapid uptake of this new technology despite paucity of evidence about its uses. CONCLUSIONS: As new evidence is generated, use of this technology will need to be monitored to minimize the risk of overuse and unintended downstream consequences.
BACKGROUND: Clinical applications of magnetic resonance imaging (MRI) of the breast have expanded across the breast cancer detection and control spectrum over the past decade. Use appears to be growing, although evidence for or against its use is still accumulating. METHODS: Using electronic health plan and medical record data, we documented early trends in breast MRI use from 2000 through 2004 in a large community practice setting with approximately 82,000 eligible female patients. During the study period, 225 women received at least one breast MRI; of those, 64 had subsequent MRI (for a total of 333 MRIs). RESULTS: Utilization grew from 6 MRIs in 2000 to 112 in 2004, with increasing use for screening, diagnosis, disease staging/treatment, and surveillance purposes. Diagnostic use accounted for nearly half of the breast MRIs (164 of 333). In this community-based practice, there was rapid uptake of this new technology despite paucity of evidence about its uses. CONCLUSIONS: As new evidence is generated, use of this technology will need to be monitored to minimize the risk of overuse and unintended downstream consequences.
Authors: M Kriege; C T Brekelmans; C Boetes; E J Rutgers; J C Oosterwijk; R A Tollenaar; R A Manoliu; R Holland; H J de Koning; J G Klijn Journal: Fam Cancer Date: 2001 Impact factor: 2.375
Authors: Rajini Katipamula; Amy C Degnim; Tanya Hoskin; Judy C Boughey; Charles Loprinzi; Clive S Grant; Kathleen R Brandt; Sandhya Pruthi; Christopher G Chute; Janet E Olson; Fergus J Couch; James N Ingle; Matthew P Goetz Journal: J Clin Oncol Date: 2009-07-27 Impact factor: 44.544
Authors: John W Gorechlad; Elizabeth B McCabe; John H Higgins; Donald S Likosky; Petra J Lewis; Kari M Rosenkranz; Richard J Barth Journal: Ann Surg Oncol Date: 2008-02-12 Impact factor: 5.344
Authors: Christoph I Lee; Laura Ichikawa; Michele C Rochelle; Karla Kerlikowske; Diana L Miglioretti; Brian L Sprague; Wendy B DeMartini; Karen J Wernli; Bonnie N Joe; Bonnie C Yankaskas; Constance D Lehman Journal: Acad Radiol Date: 2014-08-07 Impact factor: 3.173
Authors: Courtney K Morrison; Leah C Henze Bancroft; Wendy B DeMartini; James H Holmes; Kang Wang; Ryan J Bosca; Frank R Korosec; Roberta M Strigel Journal: Invest Radiol Date: 2017-04 Impact factor: 6.016
Authors: Roberta M Strigel; Jennifer Rollenhagen; Elizabeth S Burnside; Mai Elezaby; Amy M Fowler; Frederick Kelcz; Lonie Salkowski; Wendy B DeMartini Journal: Acad Radiol Date: 2016-12-13 Impact factor: 3.173
Authors: Cameron B Haas; Larissa Nekhlyudov; Janie M Lee; Sara H Javid; Mary Bush; Dianne Johnson; Timothy Gleason; Cary Kaufman; Jennifer Specht; Sean Stitham; Karen J Wernli Journal: Breast Cancer Res Treat Date: 2020-04-17 Impact factor: 4.872
Authors: Karen J Wernli; Wendy B DeMartini; Laura Ichikawa; Constance D Lehman; Tracy Onega; Karla Kerlikowske; Louise M Henderson; Berta M Geller; Mike Hofmann; Bonnie C Yankaskas Journal: JAMA Intern Med Date: 2014-01 Impact factor: 21.873
Authors: Natasha K Stout; Larissa Nekhlyudov; Lingling Li; Elisabeth S Malin; Dennis Ross-Degnan; Diana S M Buist; Marjorie A Rosenberg; Marina Alfisher; Suzanne W Fletcher Journal: JAMA Intern Med Date: 2014-01 Impact factor: 21.873
Authors: Roberta M Strigel; Erin Bravo; Amye J Tevaarwerk; Bethany M Anderson; Amy L Stella; Heather B Neuman Journal: Clin Breast Cancer Date: 2020-10-17 Impact factor: 3.225